Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Nov 6;169(9):619-627.
doi: 10.7326/M18-1161. Epub 2018 Oct 30.

Clinical Outcomes Associated With Sickle Cell Trait: A Systematic Review

Rakhi P Naik  1 , Kim Smith-Whitley  2 , Kathryn L Hassell  3 , Nkeiruka I Umeh  4 , Mariane de Montalembert  5 , Puneet Sahota  2 , Carlton Haywood Jr  6 , Jean Jenkins  4 , Michele A Lloyd-Puryear  7 , Clinton H Joiner  8 , Vence L Bonham  4 , Gregory J Kato  9
Affiliations

Clinical Outcomes Associated With Sickle Cell Trait: A Systematic Review

Rakhi P Naik et al. Ann Intern Med. .

Abstract

Background: Although sickle cell trait (SCT) is largely a benign carrier state, it may increase risk for certain clinical outcomes.

Purpose: To evaluate associations between SCT and clinical outcomes in children and adults.

Data sources: English-language searches of PubMed, CINAHL, the Cochrane Library, Current Contents Connect, Scopus, and Embase (1 January 1970 to 30 June 2018) and bibliographies of review articles.

Study selection: Observational controlled studies (published in English) in children or adults that examined an association between SCT and any of 24 clinical outcomes specified a priori in the following 6 categories: exertion-related injury; renal, vascular, pediatric, and surgery- or trauma-related outcomes; and overall mortality.

Data extraction: A single reviewer extracted study data, which was checked by another; 2 reviewers independently assessed study quality; and strength of evidence was assessed by consensus.

Data synthesis: Of 7083 screened studies, 41 met inclusion criteria. High-strength evidence supported a positive association between SCT and risk for pulmonary embolism, proteinuria, and chronic kidney disease. Moderate-strength evidence supported a positive association between SCT and exertional rhabdomyolysis and a null association between SCT and deep venous thrombosis, heart failure or cardiomyopathy, stroke, and pediatric height or weight. Absolute risks for thromboembolism and rhabdomyolysis were small. For the remaining 15 clinical outcomes, data were insufficient or strength of evidence was low.

Limitation: Publication bias was possible, and high-quality evidence was scant.

Conclusion: Sickle cell trait is a risk factor for a few adverse health outcomes, such as pulmonary embolism, kidney disease, and exertional rhabdomyolysis, but does not seem to be associated with such complications as heart failure and stroke. Insufficient data or low-strength evidence exists for most speculated complications of SCT.

Primary funding source: National Human Genome Research Institute.

PubMed Disclaimer

Figures

Figure.
Figure.
Evidence search and selection.
See this image and copyright information in PMC

References

    1. Taylor SM, Parobek CM, Fairhurst RM. Haemoglobinopathies and the clinical epidemiology of malaria: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12:457–68. [PMID: ] doi:10.1016/S1473-3099(12)70055-5 - DOI - PMC - PubMed
    1. Ojodu J, Hulihan MM, Pope SN, Grant AM; Centers for Disease Control and Prevention (CDC). Incidence of sickle cell trait—United States, 2010. MMWR Morb Mortal Wkly Rep. 2014;63:1155–8. [PMID: ] - PMC - PubMed
    1. Naik RP, Haywood C Jr. Sickle cell trait diagnosis: clinical and social implications. Hematology Am Soc Hematol Educ Program. 2015;2015:160–7. [PMID: ] doi:10.1182/asheducation-2015.1.160 - DOI - PMC - PubMed
    1. Grant AM, Parker CS, Jordan LB, Hulihan MM, Creary MS, Lloyd-Puryear MA, et al. Public health implications of sickle cell trait: a report of the CDC meeting. Am J Prev Med. 2011;41:S435–9. [PMID: ] doi:10.1016/j.amepre.2011.09.012 - DOI - PubMed
    1. World Health Organization Regional Committee for Africa. Sickle-cell disease: a strategy for the WHO African region. 22 June 2010. Accessed at http://apps.who.int/iris/bitstream/10665/1682/1/AFR-RC60-8.pdf on 1 February 2018.

Publication types